Continuing Sotorasib Development by Uncovering Synergistic Combination Strategies to Treat Mutated Colorectal Cancer
- Generating data in a 4% world: Doing more with less
- Highlighting considerations for design of pivotal phase 3 trial
- Uncovering a robust path to achieve regulatory approval